MedTrace Logo

Central and Peripheral Adiposity and Iron Absorption

NCT03642223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2019-03-28

No results posted yet for this study

Summary

Adiposity is a state of sub-clinical inflammation, thus hepcidin is increased in adiposity, often leading to iron deficiency in this population group. Central adiposity is generally considered having a greater negative effect on health compared to peripheral adiposity. Whether this can be also seen in hepcidin and thereby in iron absorption is uncertain.

Conditions

  • Adiposity
  • Iron-deficiency

Interventions

OTHER

Stable iron isotopes

Participants have to consume a test meal containing stable iron isotopes in order to determine iron absorption

Sponsors & Collaborators

  • American University of Beirut Medical Center

    collaborator OTHER

  • Swiss Federal Institute of Technology

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-10
Primary Completion
2018-10-18
Completion
2018-10-18

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03642223 on ClinicalTrials.gov